You or your patients can contact with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled. Be proactive, take control into your hands and talk to your doctor to see if DUPIXENT is right for you. No initial or routine blood work required, per Prescribing Information. Please ensure that you are filling out the correct form that corresponds to the appropriate indication. with eosinophilic esophagitis Vaccinations: Consider completing all age-appropriate vaccinations as recommended by current immunization guidelines prior to initiating DUPIXENT. moderate-to-severe asthma THERACOM INC provides services related to medication and prescriptions. Atopic Dermatitis: DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dysport. are pregnant or plan to become pregnant. 3. Acute Asthma Symptoms or Deteriorating Disease: Do not use DUPIXENT to treat acute asthma symptoms, acute exacerbations, acute bronchospasm or status asthmaticus. phenotype or with oral Program has an annual maximum of $13,000. Position: Associate Director, Forecasting - Respiratory (Dupixent)<br>** DESCRIPTION** :<br><br>The <br>** Associate Director, Forecasting** **-*<br>* ** Respiratory<br>* * will be responsible for leading commercial forecasting activities for Dupixent's US Respiratory portfolio as a part of the Commercial Strategy & Insights team within the Sanofi US Specialty Care Business Operations . A list of potential codes is provided within the Enrollment Form for reference. With our clinical expertise in the illnesses we treat, deep knowledge of relevant medical research, and a thorough understanding of prior authorization requirements, Meijer's pharmacists and nurses are trusted advisors for physicians' offices and patients. Show More. Certain specialty medication may not qualify. Conjunctivitis also occurred more frequently in chronic rhinosinusitis with nasal polyposis subjects and prurigo nodularis subjects who received DUPIXENT compared to those who received placebo. Healthcare providers should be alert to vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy presenting in their patients with eosinophilia. Many specialty medications, such as DUPIXENT, have longer turnaround times because of the prior authorization process. Entecavir. DUPIXENT is indicated for the following conditions: Uncontrolled Moderate-to-Severe Consider ophthalmological examination for patients who develop conjunctivitis that does not resolve following standard treatment or signs and symptoms suggestive of keratitis, as appropriate. Policy: Note: The provision of physician samples does not guarantee coverage under the provisions of the pharmacy benefit. Directions for use : Quantity: Duration of therapy: J-Code: . THIS IS NOT INSURANCE. After you have determined DUPIXENT is appropriate for your patient and written them a prescription: Submit theDUPIXENT MyWayEnrollment Form, Submit PA and Letter of Medical Necessity (optional) and include all required documentation (a copy of your chart notes with details of diagnosis, disease severity, and treatment history), Receive status updates from yourDUPIXENT MyWayCoordinator. A causal association between DUPIXENT and these conditions has not been established. Explore our comprehensive guides and video resources for more information regarding your condition. DUPIXENT MyWay is a patient support program that can help enable access to DUPIXENT and offers financial assistance for eligible patients, one-on-one nursing support, and more. Meijer Specialty PharmacyCorporate Offices & Patient Services. If a clinically significant hypersensitivity reaction occurs, institute appropriate therapy and discontinue DUPIXENT. Navigating Prior Authorizations & Appeals, DUP.22.09.0183Last Update: October 2022. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. that can help with the an independent company that provides pharmacy benefit management services on behalf of our health plans. with an Eosinophilic Your email is on its way. Click to skip to content. Hypersensitivity: Hypersensitivity reactions, including anaphylaxis, serum sickness or serum sickness-like reactions, angioedema, generalized urticaria, rash, erythema nodosum, and erythema multiforme have been reported. Select the first letter of a specialty condition to see the list of covered brand and generic medications. To send an electronic prescription to CarelonRx Specialty Pharmacy, please search for CarelonRx Specialty Pharmacy in your ePrescribing platform. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. to contact Regeneron Pharmaceuticals, Inc. 2022 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. Enter your email address and we will send you your personalized guide. DUPIXENT MyWayis a patient support program designed to help you get access to DUPIXENT. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back. This will allow the specialty pharmacy to conduct the benefits investigation, and DUPIXENT MyWay will provide additional support to the patient. Once enrolled, a benefits investigation to determine coverage begins. Download our app. Please refer to Regeneron's Privacy Noticeand Sanofi'sPrivacy Policyfor more information regarding processing of your personal data. to contact Regeneron Pharmaceuticals, Inc. 2022 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. We support specialty treatments and take a hands-on approach to patient care that makes a meaningful imprint on the health and quality of life of each patient. DUPIXENT andDUPIXENT MyWay are registered trademarks of Sanofi Biotechnology. In an open-label extension study, the long-term safety profile of DUPIXENT TCS in pediatric patients observed through Week 52 was consistent with that seen in adults with atopic dermatitis, with hand-foot-and-mouth disease and skin papilloma (incidence 2%) reported in patients 6 months to 5 years of age. mechanism of dupilumab action Theracom in Rockville - Pharmacy Location, Contact Theracom - NPI 1568443489 Theracom (THERACOM) is a Specialty Pharmacy in Rockville, Maryland. You are on primary menu. DUPIXENT doesnt broadly suppress the immune system. DUPIXENT and offers financial assistance for eligible patients, one-on-one Cases of eosinophilic pneumonia were reported in adult subjects who participated in the asthma development program and cases of vasculitis consistent with EGPA have been reported with DUPIXENT in adult subjects who participated in the asthma development program as well as in adult subjects with co-morbid asthma in the CRSwNP development program. They will begin the benefits investigation and inform your office of the next steps. Corren J. comments sorted by Best Top New Controversial Q&A Add a . aTheDUPIXENT MyWayteam will research each patients situation and determine eligibility. When you fill your specialty prescription with Magellan Rx Pharmacy, you are automatically enrolled in MRx Cares. Any savings provided by the program may vary depending on patients' out-of-pocket costs. Completion of a written evaluation of the Dupixent, the competition drug, including recommendations for formulary placement . Conjunctivitis and keratitis have been reported with DUPIXENT in postmarketing settings, predominantly in AD patients. DUPIXENT MyWaywill also remind the healthcare professional when the authorization is up for reapproval. We're here to make a difference Senderra continues to provide specialized care to Patients, service to Prescribers, certainty to Payers, and support to our Pharma partners. Provides assistance navigating the insurance process. You will most likely receive it as a shipment from a specialty pharmacy. to contact Regeneron Pharmaceuticals, Inc. 2022 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. Epclusa . Please inform patients thatDUPIXENT MyWaywill be contacting them through their preferred method of communication and that maintaining communication is important for them to receive support fromDUPIXENT MyWay. years and older with Text "Start" to 877-222-7336. Collaborate with US Dupixent Finance & other US Specialty Care forecasters in forecast cycle planning to promote harmonization across therapeutic areas. CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSwNP) Ages 18+ Years, EOSINOPHILIC ESOPHAGITIS (EoE) PROGRAM, https://mothertobaby.org/ongoing-study/dupixent/. Asthma: DUPIXENT is indicated as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Sanofi US and Regeneron provide these links as a service to its website visitors and users; however, they take no responsibility for the information on any website but their own. DUPIXENT, a biologic, is a type of medication that is processed in the body differently than oral medications (pills), or steroids. Fill out the enrollment form with your patients. ASTHMA Ages 6+ Years, Add-on Maintenance Treatment for Uncontrolled students and our specialty pharmacy family at the ashp midyear . AcariaHealth is the preferred specialty pharmacy provider of Ambetter from Superior HealthPlan. Enter your email address and we will send you your personalized guide. Specialty therapy isn't a hands-off process. If symptoms persist or worsen, consider rheumatological evaluation and/or discontinuation of DUPIXENT. 907-644-6800, 800 . Read through customer reviews, check out their past projects and then request a quote from the best specialty contractors near you. Its an injection given under the skin (subcutaneous injection). are breastfeeding or plan to breastfeed. Dupixent (dupilumab) is a brand-name prescription medication. If precertification requirements apply, Aetna considers this drug to be medically necessary for those members who meet the following precertification criteria: How do companies and individuals find a program that works in their best interests? In children 6 to 11 years old using Dupixent or placebo plus a topical corticosteroid for severe eczema, studies at 16 weeks show that . DUPIXENT can be used with or without topical corticosteroids. Be sure to check your inbox. Dupixent may cause serious side effects. It is not known if DUPIXENT is safe and effective in children with prurigo nodularis under 18 years of age. Risk Associated with Abrupt Reduction of Corticosteroid Dosage: Do not discontinue systemic, topical, or inhaled corticosteroids abruptly upon initiation of DUPIXENT.